Patents by Inventor Liangru Contois

Liangru Contois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCING THE THERAPEUTIC ACTIVITY OF IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20210155696
    Abstract: The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
    Type: Application
    Filed: December 9, 2020
    Publication date: May 27, 2021
    Inventors: Peter C. Brooks, Jennifer M. Caron, Liangru Contois
  • ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20210100901
    Abstract: The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
    Type: Application
    Filed: December 3, 2020
    Publication date: April 8, 2021
    Inventors: Peter C. Brooks, Jennifer M. Caron, Liangru Contois
  • Enhancing the therapeutic activity of immune checkpoint inhibitor
    Patent number: 10906977
    Abstract: The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: February 2, 2021
    Assignee: Maine Medical Center Research Institute
    Inventors: Peter C. Brooks, Jennifer M. Caron, Liangru Contois
  • Enhancing the therapeutic activity of an immune checkpoint inhibitor
    Patent number: 10881732
    Abstract: The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: January 5, 2021
    Assignee: Maine Medical Center Research Institute
    Inventors: Peter C. Brooks, Jennifer M. Caron, Liangru Contois
  • ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20170065716
    Abstract: The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
    Type: Application
    Filed: June 1, 2016
    Publication date: March 9, 2017
    Inventors: Peter C. Brooks, Jennifer M. Caron, Liangru Contois